Starbucks in hot water over China prices

  @vharrisoncnn October 21, 2013: 8:30 AM ET
starbucks china

Starbucks has been accused of charging more for coffee in China than in other countries.


Starbucks is under fire in China over how much it charges for coffee as a wave of criticism of Western companies' business practice continues.

Separate reports from state-backed China Central Television and the China Daily newspaper in the past week have accused the company of making consumers pay more for its coffee and related products in China than in other markets, including the United States.

The CCTV report said a medium size latte costs 27 yuan or $4.40 in China, compared with $3.20 in Chicago and about $4 in London.

The reports also said a Starbucks coffee mug - which is made in China - sells for between $10 and $14 in the U.S., and as much as $18 in China.

Starbucks (SBUX, Fortune 500) was not immediately available for comment.

Related: Starbucks CEO Schultz has another grande plan

The Seattle-based coffee chain is doing well in China. Strong sales contributed to a 30% year-on-year jump in revenues from its Asia-Pacific region, according to a report published in July.

The heat on Starbucks pricing in China comes as local authorities step up the pressure on international companies.

The country's state media launched an aggressive campaign against Apple (AAPL, Fortune 500)in March, after CCTV broadcast an expose on the tech firm's warranty standards and customer service in China.

CCTV reported that Apple was using refurbished parts to repair products in China, and limiting some warranties to one year.

Related: Apple dust-up leaves Chinese wondering

At the same time, a series of investigations into price fixing and anti-competitive conduct targeted U.S. and other global companies.

A powerful state agency in China announced record fines against five international dairy firms in August after they were accused of fixing the prices of baby formula.

Mead Johnson, Abbott Laboratories (ABT, Fortune 500) and France's Danone (DANOY) were among those slugged with penalties.

Related: China opens investigation into drug prices

Pharmaceutical companies are also being probed as part of a wider anti-corruption crackdown in China.

Chinese regulators are investigating production costs and price setting practices at 60 pharmaceutical companies, including GlaxoSmithKline (GLAXF), Astellas (ALPMF) and Sandoz. To top of page

Join the Conversation
CNNMoney Sponsors
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.